Related Experiment Video
Updated: Jun 13, 2026

10:25
"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection
Published on: February 19, 2019
A microarray analysis of early activated pathways in concanavalin A-induced hepatitis
Qing-Yi Cao1, Feng Chen, Jie Li
1State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, China.
Journal of Zhejiang University. Science. B
|May 6, 2010
Summary
Toll-like receptor (TLR) signaling drives early fulminant hepatitis in mice by activating immune cells. This leads to hepatocyte apoptosis and liver injury, revealing critical early-stage mechanisms.
Area of Science:
- Immunology
- Hepatology
- Molecular Biology
Background:
- Fulminant hepatitis (FH) is a severe liver condition with complex initiation and progression mechanisms.
- Understanding early-stage FH is crucial for developing effective therapeutic strategies.
Purpose of the Study:
- To elucidate the early-stage mechanisms of fulminant hepatitis (FH) in a mouse model.
- To identify critical molecular pathways involved in the initiation and progression of FH.
Main Methods:
- Concanavalin A (Con A) was administered to BALB/c mice, with samples collected at 1, 3, and 6 hours post-injection.
- Gene expression profiling was performed using Affymetrix GeneChip Mouse 430 2.0 Array.
- Microarray data underwent differential gene expression and pathway enrichment analysis.
Main Results:
- A significant number of differentially expressed genes were identified at all time points.
- Early phases (0-3 hours) showed enrichment in immune response and inflammation pathways, including Toll-like receptor (TLR) and mitogen-activated protein kinase (MAPK) signaling.
- Later phases (3-6 hours) were characterized by enrichment in metabolic process pathways.
Conclusions:
- The Toll-like receptor (TLR) signaling pathway is a dominant early response in Con A-induced FH.
- TLR signaling promotes type I cytokine production, recruiting and activating T and NK cells.
- Activated T/NK cells induce hepatocyte apoptosis via death receptor pathways, leading to liver injury.

